NeuroTrials Research Selected for Two New Studies

Atlanta, GA—NeuroTrials Research, an independent research organization in Atlanta devoted to investigational drug, medical device, consumer research and diagnostic testing, has been selected to conduct two new clinical research studies of an investigational sleep medication on the breathing function of participants with Chronic Obstructive Pulmonary Disorder (COPD) or Obstructive Sleep Apnea (OSA).

Nationally recognized physicians and researchers founded NeuroTrials over a decade ago. NeuroTrials continues to attract important Phase II-IV studies that impact the health and welfare of residents in Atlanta and nationwide. Over 24 million Americans have been diagnosed with COPD and as many as 1 in 3 American men suffer from OSA.

“We are excited to have the opportunity to propel research forward on two important medical conditions simultaneously” said Dr. Russell Rosenberg, CEO of NeuroTrials Research. Experienced in both pulmonary and sleep disorder clinical studies, this marks the fifth OSA study and tenth COPD study an independent sponsor has selected NeuroTrials to conduct. NeuroTrials will begin enrolling participants for both studies this month. Patients diagnosed with OSA or COPD can contact NeuroTrials at 404-851-9934 for more information. For full details on both studies, visit neurotrials.com/studies.aspx.

Interested participants can also follow NeuroTrials on Facebook (facebook.com/neurotrials) and Twitter (twitter.com/neurotrials) for real-time updates on all enrolling studies.

Russell Rosenberg, PhD, elected chairman of the National Sleep Foundation

Russell Rosenberg, PhD, has been elected chairman of the National Sleep Foundation. Dr. Rosenberg will begin his one-year term as chairman on July 1. Dr. Rosenberg is a board certified sleep specialist with 26 years of clinical and research experience. He is the Founder and CEO of the Atlanta School of Sleep Medicine and Technology.

As chairman, Dr. Rosenberg will lead the National Sleep Foundation’s board of directors, comprised of physicians, scientists, and business professionals.

“It’s an honor and a privilege to serve as chairman of the National Sleep Foundation. We’ll continue on our mission to improve sleep health in this country. Getting good sleep is as important as eating the proper diet and exercising regularly.” said Dr. Rosenberg.

Serving on the board of directors since 2005, Dr. Rosenberg is the current vice-chair of the National Sleep Foundation. Dr. Rosenberg also served as the task force chair for the National Sleep Foundation’s 2011 Sleep in America poll released in March.

The National Sleep Foundation is dedicated to improving sleep health and safety through education, public awareness, and advocacy. The National Sleep Foundation is a charitable, educational and scientific not-for-profit organization located in Washington, DC. Its membership includes researchers and clinicians focused on sleep medicine, professionals in the health, medical and science fields, individuals, patients, families affected by drowsy driving and more than 900 healthcare facilities throughout North America. Dr. Rosenberg will be the National Sleep Foundation’s 9th chairman of the board.

Neurotrials using driving simulator

Researchers at NeuroTrials, a nationally recognized sleep research center in Atlanta are using a new driving simulator to study the influence of insomnia on driving. The simulator, which functions in a controlled environment at the research center, tests both healthy sleepers and insomniacs on their driving skills, alertness and reaction time during monotonous drives and on curvy roads.

Findings from the National Sleep Foundation’s new 2011 Sleep in America poll suggest that Americans aren’t getting the sleep they need and this loss of satisfactory sleep means more individuals are dozing off while driving.

Dr. Michael Lacey, a board-certified sleep specialist and neurologist who directs the Atlanta Sleep Medicine Clinic treats many patients who admit to dozing while driving. “Many of my patients admit to drowsy driving, often resulting in serious accidents. Drowsy drivers are a risk to themselves and others on our roads. Identification and subsequent treatment of sleep disorders in these patients can make a tremendous difference in their ability to remain alert and safe.”

According to the NSF poll, half of 19-29 years olds admit they drove while drowsy at least once in the past month. More than 40% of individuals aged 30-45 years, 30% of those 16-18, and 28% of participants aged 46-64 years also admitted to drowsy driving within the last month.

Additionally, one in ten of those aged 16-45 say they drive drowsy once or twice a week. As sleep quality suffers and drowsy driving continues to rise, the driving study at NeuroTrials Research offers physicians and researchers the opportunity to safely examine the science behind sleep and impaired driving.

“We hope that investigating underlying causes and stages of drowsy driving will lead to more effective methods of deterring it”, said Dr. Russell Rosenberg, CEO of NeuroTrials and Vice Chair of the National Sleep Foundation. “Improving sleep quality and treating chronic sleep disorders can lead to better health and increased public safety for all Americans.”

NeuroTrials is currently seeking participants for the driving simulator study. The study requires the participation of elderly insomniacs and healthy sleepers. If you are 65 years or older, you may qualify to participate in this study. In addition to all study-related care provided at no charge, eligible participants may be compensated up to $1650 for time and travel. Call 404-851-9934 or visit http://www.neurotrials.com for more information.